title: A Mycobacterium tuberculosis-derived lipid inhibits membrane fusion by modulating lipid membrane domains.
abstract: Tuberculosis is an infectious and potentially fatal disease caused by the acid-fast bacillus Mycobacterium tuberculosis (MTB). One hallmark of a tuberculosis infection is the ability of the bacterium to subvert the normal macrophage defense mechanism of the host immune response. Lipoarabinomannan (LAM), an integral component of the MTB cell wall, is released when MTBs are taken into phagosomes and has been reported to be involved in the inhibition of phago-lysosomal (P-L) fusion. However, the physical chemistry of the effects of LAM on lipid membrane structure relative to P-L fusion has not been studied. We produced membranes in vitro composed of dioleoylphosphatidylcholine, sphingomyelin, and cholesterol to simulate phagosomal lipid membranes and quantified the effects of the addition of LAM to these membranes, using fluorescence resonance energy transfer assays and atomic force microscopy. We found that LAM inhibits vesicle fusion and markedly alters lipid membrane domain morphology and sphingomyelin-chollesterol/dioleoylphosphatidylcholine ratios. These data demonstrate that LAM induces a dramatic reorganization of lipid membranes in vitro and clarifies the role of LAM in the inhibition of P-L fusion and the survival of the MTB within the macrophage.
authors: Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, 4-1-8, Honcho, Kawaguchi, Saitama, 332-0012, Japan.
authors: Eri
authors: E
authors: Hayakawa
authors: Fuyuki
authors: F
authors: Tokumasu
authors: Glenn A
authors: GA
authors: Nardone
authors: Albert J
authors: AJ
authors: Jin
authors: Vince A
authors: VA
authors: Hackley
authors: James A
authors: JA
authors: Dvorak
mesh_terms: D008051:Lipid Bilayers / Q000737:chemistry*; D008070:Lipopolysaccharides / Q000737:chemistry*; D008560:Membrane Fluidity; D008561:Membrane Fusion; D021962:Membrane Microdomains / Q000737:chemistry*; D008968:Molecular Conformation; D009169:Mycobacterium tuberculosis / Q000737:chemistry*
chemical_list: D008051:Lipid Bilayers; D008070:Lipopolysaccharides; C050016:lipoarabinomannan
references: Ultramicroscopy. 2004 Aug;100(3-4):135-43
references: 15231303
references: Science. 2000 Jun 2;288(5471):1647-50
references: 10834844
references: Biopolymers. 1967 Feb;5(2):135-48
references: 6040712
references: Biochim Biophys Acta. 1970 Jun 9;210(1):116-26
references: 4989541
references: Proc Natl Acad Sci U S A. 1976 Jul;73(7):2510-4
references: 821057
references: Inflammation. 1977 Jun;2(2):83-91
references: 617805
references: J Biol Chem. 1986 Sep 15;261(26):12345-51
references: 3091602
references: J Immunol. 1988 Jan 15;140(2):634-40
references: 2826597
references: J Immunol. 1994 Sep 15;153(6):2568-78
references: 8077667
references: Annu Rev Biochem. 1995;64:29-63
references: 7574484
references: Science. 1995 Oct 27;270(5236):610-4
references: 7570018
references: J Immunol. 1996 Jun 1;156(11):4377-83
references: 8666810
references: Chem Phys Lipids. 1996 Jul 15;81(2):203-13
references: 8810049
references: J Biol Chem. 2001 Jan 5;276(1):329-33
references: 11020382
references: Glycoconj J. 2000 Mar-Apr;17(3 -4):199-204
references: 11201791
references: Traffic. 2000 Mar;1(3):235-47
references: 11208107
references: Biochemistry. 2001 Jul 27;40(28):8292-9
references: 11444975
references: Adv Drug Deliv Rev. 2001 Jul 28;49(3):301-15
references: 11551401
references: Biophys J. 2003 Apr;84(4):2609-18
references: 12668469
references: Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5437-42
references: 12702770
references: Ultramicroscopy. 2003 Oct-Nov;97(1-4):217-27
references: 12801674
references: FEBS Lett. 2003 Jul 17;547(1-3):101-6
references: 12860394
references: Infect Immun. 2003 Aug;71(8):4684-90
references: 12874349
references: J Exp Med. 2003 Aug 18;198(4):653-9
references: 12925680
references: J Cell Biol. 2003 Nov 24;163(4):879-88
references: 14623870
references: Biochem Biophys Res Commun. 1996 Sep 24;226(3):645-9
references: 8831670
references: Cell. 1998 Mar 20;92(6):759-72
references: 9529252
references: Eur Biophys J. 1999;28(3):187-99
references: 10192934
references: Cell. 1999 May 14;97(4):435-47
references: 10338208
references: FEMS Immunol Med Microbiol. 1999 May;24(1):11-7
references: 10340707
references: Scand J Immunol. 2004 Nov;60(5):463-70
references: 15541038
references: J Mol Biol. 2004 Dec 3;344(4):907-18
references: 15544801
references: Cell Mol Life Sci. 2005 Jan;62(2):179-87
references: 15666089
references: Acta Med Croatica. 2004;58(4):323-8
references: 15700689
references: Biophys J. 2005 Feb;88(2):1120-33
references: 15542550
references: J Exp Med. 2005 Oct 3;202(7):987-99
references: 16203868
references: Biophys J. 2006 Mar 1;90(5):1661-75
references: 16339880
references: Methods Enzymol. 2003;372:300-19
references: 14610820
references: Appl Biochem Biotechnol. 2004 Jul-Sep;118(1-3):253-67
references: 15304754